https://orcid.org/0000-0003-0096-6852
References
- Bézivin C, Tomasi S, Lohézic-Le Dévéhat F, Boustie J. 2003. Cytotoxic activity of somelichen extracts on murine and human cancer cell lines. Phytomedicine. 10(6–7):499–503.
- Bormio Nunes JH, Simoni DA, Braga LEO, Ruiz ALTG, Ernesto de Carvalho J, Corbi PP. 2019. Synthesis, characterization, crystal structure and in vitro antiproliferative assays of the 2-thiouracilato(triphenylphosphine) gold(I) complex. J Mol Struct. 1178:169–178.
- Federici E, Palazzino G, Nicoletti M, Galeffi C. 2000. Antiplasmodial activity of the alkaloids of Peschiera fuchsiaefolia. Planta Med. 66(1):93–95.
- Figueiredo ER, Vieira IJC, Souza JJ, Braz-Filho R, Mathias L, Kanashiro MM, Côrtes FH. 2010. Isolamento, identificação e avaliação da atividade antileucêmica de alcaloides indólicos monoterpênicos de Tabernaemontana salzmannii (A. DC.), Apocynaceae. Rev Bras Farmacogn. 20(5):675–681.
- Fouche G, Cragg GM, Pillay P, Kolesnikova N, Maharaj VJ, Senabe J. 2008. In vitro anticancer screening of South African plants. J Ethnopharmacol. 119(3):455–461.
- Marinho FF, Simões AO, Barcellos T, Moura S. 2016. Brazilian Tabernaemontana genus: indole alkaloids and phytochemical activities. Fitoterapia. 114:127–137.
- Matozinhos CN, Konno TUP. 2011. Diversidade taxonômica de Apocynaceae na Serra Negra, MG, Brasil. Hoehnea. 38(4):569–595.
- Mattiuzzi C, Lippi G. 2019. Current cancer epidemiology. J Epidemiol Glob Health. 9(4):217–222.
- Miguel M, Calvo E. 2019. Early-phase clinical drug development of novel agents: a changing paradigm. Ann Oncol. 30(7):1033–1037.
- Naidoo CM, Naidoo Y, Dewir YH, Murthy HN, Hendawy SE, Suhaibani NA. 2021. Major bioactive alkaloids and biological activities of Tabernaemontana species (Apocynaceae). Plants. 10(2):313–327.
- Nemes A, Szántay C, Czibula L, Greiner I. 2008. Synthesis of metabolites of cis and trans apovincamine derivatives. Arkivoc. 2008(3):154–166.
- Newman DJ, Cragg GM. 2020. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 83(3):770–803.
- Oliveira P. F d, Alves JM, Damasceno JL, Oliveira RAM, Dias HJ, Crotti AEM, Tavares DC. 2015. Cytotoxicity screening of essential oils in cancer cell lines. Braz J Pharmacogn. 25(2):183–188.
- Pereira PS, França SC, Oliveira PVA, Breves CMS, Pereira SIV, Sampaio SV, Nomizo A, Dias DA. 2008. Chemical constituents from Tabernaemontana catharinensis root bark: a brief NMR review of indole alkaloids and in vitro cytotoxicity. Quím Nova. 31(1):20–24.
- Rosales P, Gowe A, Moura S. 2019. Extraction, isolation and in vitro evaluation of affinisine from Tabernaemontana catharinensis in human melanoma cells. Bioorg Chem. 90:1–7.
- Rosales PF, Marinho FF, Gower A, Chiarello M, Canci B, Roesch-Ely M, Paula FR, Moura S. 2019. Bio-guided search of active indole alkaloids from Tabernaemontana catharinensis: antitumour activity, toxicity in silico and molecular modelling studies. Bioorg Chem. 85:66–74.
- Sauter ER. 2020. Cancer prevention and treatment using combination therapy with natural compounds. Expert Rev Clin Pharmacol. 13(3):265–285.
- Suffness M, Pezzuto JM. 1990. Assays related to cancer drug discovery. In: Hostettmann, K, editor. Methods in plant biochemistry: assays for bioactivity. London: Academic Press; p. 71–133.
- Van Beek TA, Verpoorte R, Svendsen AB, Leeuwenberg AJ, Bisset NG. 1984. Tabernaemontana L.: a review of its taxonomy, phytochemistry, ethnobotany and pharmacology. J Ethnopharmacol. 10(1):1–156.
- WHO, World Health Organization. 2019. Cancer control: knowledge in action: diagnosis and treatment.
- Xu D, Xu Z. 2020. Indole alkaloids with potential anticancer activity. CTMC. 20(21):1938–1949.